| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |